PharmaCyte Biotech | 8-K:重大事件
PharmaCyte Biotech | ARS:年度報告
PharmaCyte Biotech | DEF 14A:股東委託書決議
PharmaCyte Biotech | 10-Q:季度報表
PharmaCyte Biotech | SC 13G:超過5%持股股東披露文件-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)等
PharmaCyte Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%)等
PharmaCyte Biotech:2024財年二季報
PharmaCyte Biotech | 3:首次持股聲明-股東 PharmaCyte Biotech, Inc.
PharmaCyte Biotech | 8-K:重大事件
PharmaCyte Biotech | 4:持股變動聲明-董事 WEINSTEIN ROBERT
PharmaCyte Biotech | 4:持股變動聲明-董事 WALKER WAYNE REMELL
PharmaCyte Biotech | 4:持股變動聲明-首席財務官 Trujillo Carlos
PharmaCyte Biotech | 4:持股變動聲明-高管 Silverman Joshua
PharmaCyte Biotech | 4:持股變動聲明-董事 SCHECHTER JONATHAN
PharmaCyte Biotech | 4:持股變動聲明-董事 Abecassis Michael M
PharmaCyte Biotech | SC 13D:超過5%持股股東披露文件-PharmaCyte Biotech, Inc.(37.0%)
PharmaCyte Biotech | 8-K:重大事件
PharmaCyte Biotech | 8-K:重大事件
PharmaCyte Biotech | EFFECT:其他
PharmaCyte Biotech | CORRESP:信函
暫無數據